Global Intravenous Immunoglobulin (IVIg) Market Size, Manufacturers, Opportunities and Forecast to 2030
Intravenous Immunoglobulin, also called gamma globulin or antibodies, is a highly purified blood product preparation that is derived from large pools of plasma donors. Plasma from approximately 1,000 to 10,000 persons is present in each unit or “lot” of Intravenous Immunoglobulin.
According to APO Research, The global Intravenous Immunoglobulin (IVIg) market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
Global Intravenous Immunoglobulin (IVIg) main players are Baxter, Grifols, CSL, Octapharma, etc. Global top four manufacturers hold a share above 65%. North America is the largest market, with a share about 45%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Intravenous Immunoglobulin (IVIg), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intravenous Immunoglobulin (IVIg).
The Intravenous Immunoglobulin (IVIg) market size, estimations, and forecasts are provided in terms of sales volume (K Bottle) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Intravenous Immunoglobulin (IVIg) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Intravenous Immunoglobulin (IVIg) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Intravenous Immunoglobulin (IVIg) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Intravenous Immunoglobulin (IVIg).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Intravenous Immunoglobulin (IVIg) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Intravenous Immunoglobulin (IVIg) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
According to APO Research, The global Intravenous Immunoglobulin (IVIg) market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
Global Intravenous Immunoglobulin (IVIg) main players are Baxter, Grifols, CSL, Octapharma, etc. Global top four manufacturers hold a share above 65%. North America is the largest market, with a share about 45%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Intravenous Immunoglobulin (IVIg), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intravenous Immunoglobulin (IVIg).
The Intravenous Immunoglobulin (IVIg) market size, estimations, and forecasts are provided in terms of sales volume (K Bottle) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Intravenous Immunoglobulin (IVIg) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Baxter
- Grifols
- CSL
- Octapharma
- Biotest
- Kedrion
- Hualan Bio
- CNBG
- Shanghai RAAS
- CBPO
- LFB Group
- BPL
- Sichuan Yuanda Shuyang
- IVIg Liquid
- IVIg Powder
- Immunodeficiency
- Autoimmune Disease
- Acute Infection
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Intravenous Immunoglobulin (IVIg) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Intravenous Immunoglobulin (IVIg) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Intravenous Immunoglobulin (IVIg).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Intravenous Immunoglobulin (IVIg) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Intravenous Immunoglobulin (IVIg) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Intravenous Immunoglobulin (IVIg) Market Size Estimates and Forecasts (2019-2030)
1.2.2 Global Intravenous Immunoglobulin (IVIg) Sales Estimates and Forecasts (2019-2030)
1.3 Intravenous Immunoglobulin (IVIg) Market by Type
1.3.1 IVIg Liquid
1.3.2 IVIg Powder
1.4 Global Intravenous Immunoglobulin (IVIg) Market Size by Type
1.4.1 Global Intravenous Immunoglobulin (IVIg) Market Size Overview by Type (2019-2030)
1.4.2 Global Intravenous Immunoglobulin (IVIg) Historic Market Size Review by Type (2019-2024)
1.4.3 Global Intravenous Immunoglobulin (IVIg) Forecasted Market Size by Type (2025-2030)
1.5 Key Regions Market Size by Type
1.5.1 North America Intravenous Immunoglobulin (IVIg) Sales Breakdown by Type (2019-2024)
1.5.2 Europe Intravenous Immunoglobulin (IVIg) Sales Breakdown by Type (2019-2024)
1.5.3 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales Breakdown by Type (2019-2024)
1.5.4 Latin America Intravenous Immunoglobulin (IVIg) Sales Breakdown by Type (2019-2024)
1.5.5 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales Breakdown by Type (2019-2024)
2 GLOBAL MARKET DYNAMICS
2.1 Intravenous Immunoglobulin (IVIg) Industry Trends
2.2 Intravenous Immunoglobulin (IVIg) Industry Drivers
2.3 Intravenous Immunoglobulin (IVIg) Industry Opportunities and Challenges
2.4 Intravenous Immunoglobulin (IVIg) Industry Restraints
3 MARKET COMPETITIVE LANDSCAPE BY COMPANY
3.1 Global Top Players by Intravenous Immunoglobulin (IVIg) Revenue (2019-2024)
3.2 Global Top Players by Intravenous Immunoglobulin (IVIg) Sales (2019-2024)
3.3 Global Top Players by Intravenous Immunoglobulin (IVIg) Price (2019-2024)
3.4 Global Intravenous Immunoglobulin (IVIg) Industry Company Ranking, 2022 VS 2023 VS 2024
3.5 Global Intravenous Immunoglobulin (IVIg) Key Company Manufacturing Sites & Headquarters
3.6 Global Intravenous Immunoglobulin (IVIg) Company, Product Type & Application
3.7 Global Intravenous Immunoglobulin (IVIg) Company Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Intravenous Immunoglobulin (IVIg) Market CR5 and HHI
3.8.2 Global Top 5 and 10 Intravenous Immunoglobulin (IVIg) Players Market Share by Revenue in 2023
3.8.3 2023 Intravenous Immunoglobulin (IVIg) Tier 1, Tier 2, and Tier
4 INTRAVENOUS IMMUNOGLOBULIN (IVIG) REGIONAL STATUS AND OUTLOOK
4.1 Global Intravenous Immunoglobulin (IVIg) Market Size and CAGR by Region: 2019 VS 2023 VS 2030
4.2 Global Intravenous Immunoglobulin (IVIg) Historic Market Size by Region
4.2.1 Global Intravenous Immunoglobulin (IVIg) Sales in Volume by Region (2019-2024)
4.2.2 Global Intravenous Immunoglobulin (IVIg) Sales in Value by Region (2019-2024)
4.2.3 Global Intravenous Immunoglobulin (IVIg) Sales (Volume & Value), Price and Gross Margin (2019-2024)
4.3 Global Intravenous Immunoglobulin (IVIg) Forecasted Market Size by Region
4.3.1 Global Intravenous Immunoglobulin (IVIg) Sales in Volume by Region (2025-2030)
4.3.2 Global Intravenous Immunoglobulin (IVIg) Sales in Value by Region (2025-2030)
4.3.3 Global Intravenous Immunoglobulin (IVIg) Sales (Volume & Value), Price and Gross Margin (2025-2030)
5 INTRAVENOUS IMMUNOGLOBULIN (IVIG) BY APPLICATION
5.1 Intravenous Immunoglobulin (IVIg) Market by Application
5.1.1 Immunodeficiency
5.1.2 Autoimmune Disease
5.1.3 Acute Infection
5.2 Global Intravenous Immunoglobulin (IVIg) Market Size by Application
5.2.1 Global Intravenous Immunoglobulin (IVIg) Market Size Overview by Application (2019-2030)
5.2.2 Global Intravenous Immunoglobulin (IVIg) Historic Market Size Review by Application (2019-2024)
5.2.3 Global Intravenous Immunoglobulin (IVIg) Forecasted Market Size by Application (2025-2030)
5.3 Key Regions Market Size by Application
5.3.1 North America Intravenous Immunoglobulin (IVIg) Sales Breakdown by Application (2019-2024)
5.3.2 Europe Intravenous Immunoglobulin (IVIg) Sales Breakdown by Application (2019-2024)
5.3.3 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales Breakdown by Application (2019-2024)
5.3.4 Latin America Intravenous Immunoglobulin (IVIg) Sales Breakdown by Application (2019-2024)
5.3.5 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales Breakdown by Application (2019-2024)
6 COMPANY PROFILES
6.1 Baxter
6.1.1 Baxter Comapny Information
6.1.2 Baxter Business Overview
6.1.3 Baxter Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Baxter Intravenous Immunoglobulin (IVIg) Product Portfolio
6.1.5 Baxter Recent Developments
6.2 Grifols
6.2.1 Grifols Comapny Information
6.2.2 Grifols Business Overview
6.2.3 Grifols Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Grifols Intravenous Immunoglobulin (IVIg) Product Portfolio
6.2.5 Grifols Recent Developments
6.3 CSL
6.3.1 CSL Comapny Information
6.3.2 CSL Business Overview
6.3.3 CSL Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 CSL Intravenous Immunoglobulin (IVIg) Product Portfolio
6.3.5 CSL Recent Developments
6.4 Octapharma
6.4.1 Octapharma Comapny Information
6.4.2 Octapharma Business Overview
6.4.3 Octapharma Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Octapharma Intravenous Immunoglobulin (IVIg) Product Portfolio
6.4.5 Octapharma Recent Developments
6.5 Biotest
6.5.1 Biotest Comapny Information
6.5.2 Biotest Business Overview
6.5.3 Biotest Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Biotest Intravenous Immunoglobulin (IVIg) Product Portfolio
6.5.5 Biotest Recent Developments
6.6 Kedrion
6.6.1 Kedrion Comapny Information
6.6.2 Kedrion Business Overview
6.6.3 Kedrion Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Kedrion Intravenous Immunoglobulin (IVIg) Product Portfolio
6.6.5 Kedrion Recent Developments
6.7 Hualan Bio
6.7.1 Hualan Bio Comapny Information
6.7.2 Hualan Bio Business Overview
6.7.3 Hualan Bio Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Hualan Bio Intravenous Immunoglobulin (IVIg) Product Portfolio
6.7.5 Hualan Bio Recent Developments
6.8 CNBG
6.8.1 CNBG Comapny Information
6.8.2 CNBG Business Overview
6.8.3 CNBG Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
6.8.4 CNBG Intravenous Immunoglobulin (IVIg) Product Portfolio
6.8.5 CNBG Recent Developments
6.9 Shanghai RAAS
6.9.1 Shanghai RAAS Comapny Information
6.9.2 Shanghai RAAS Business Overview
6.9.3 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Product Portfolio
6.9.5 Shanghai RAAS Recent Developments
6.10 CBPO
6.10.1 CBPO Comapny Information
6.10.2 CBPO Business Overview
6.10.3 CBPO Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
6.10.4 CBPO Intravenous Immunoglobulin (IVIg) Product Portfolio
6.10.5 CBPO Recent Developments
6.11 LFB Group
6.11.1 LFB Group Comapny Information
6.11.2 LFB Group Business Overview
6.11.3 LFB Group Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
6.11.4 LFB Group Intravenous Immunoglobulin (IVIg) Product Portfolio
6.11.5 LFB Group Recent Developments
6.12 BPL
6.12.1 BPL Comapny Information
6.12.2 BPL Business Overview
6.12.3 BPL Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
6.12.4 BPL Intravenous Immunoglobulin (IVIg) Product Portfolio
6.12.5 BPL Recent Developments
6.13 Sichuan Yuanda Shuyang
6.13.1 Sichuan Yuanda Shuyang Comapny Information
6.13.2 Sichuan Yuanda Shuyang Business Overview
6.13.3 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Product Portfolio
6.13.5 Sichuan Yuanda Shuyang Recent Developments
7 NORTH AMERICA BY COUNTRY
7.1 North America Intravenous Immunoglobulin (IVIg) Sales by Country
7.1.1 North America Intravenous Immunoglobulin (IVIg) Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.1.2 North America Intravenous Immunoglobulin (IVIg) Sales by Country (2019-2024)
7.1.3 North America Intravenous Immunoglobulin (IVIg) Sales Forecast by Country (2025-2030)
7.2 North America Intravenous Immunoglobulin (IVIg) Market Size by Country
7.2.1 North America Intravenous Immunoglobulin (IVIg) Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2.2 North America Intravenous Immunoglobulin (IVIg) Market Size by Country (2019-2024)
7.2.3 North America Intravenous Immunoglobulin (IVIg) Market Size Forecast by Country (2025-2030)
8 EUROPE BY COUNTRY
8.1 Europe Intravenous Immunoglobulin (IVIg) Sales by Country
8.1.1 Europe Intravenous Immunoglobulin (IVIg) Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.1.2 Europe Intravenous Immunoglobulin (IVIg) Sales by Country (2019-2024)
8.1.3 Europe Intravenous Immunoglobulin (IVIg) Sales Forecast by Country (2025-2030)
8.2 Europe Intravenous Immunoglobulin (IVIg) Market Size by Country
8.2.1 Europe Intravenous Immunoglobulin (IVIg) Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2.2 Europe Intravenous Immunoglobulin (IVIg) Market Size by Country (2019-2024)
8.2.3 Europe Intravenous Immunoglobulin (IVIg) Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC BY COUNTRY
9.1 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales by Country
9.1.1 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.1.2 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales by Country (2019-2024)
9.1.3 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales Forecast by Country (2025-2030)
9.2 Asia-Pacific Intravenous Immunoglobulin (IVIg) Market Size by Country
9.2.1 Asia-Pacific Intravenous Immunoglobulin (IVIg) Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2.2 Asia-Pacific Intravenous Immunoglobulin (IVIg) Market Size by Country (2019-2024)
9.2.3 Asia-Pacific Intravenous Immunoglobulin (IVIg) Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA BY COUNTRY
10.1 Latin America Intravenous Immunoglobulin (IVIg) Sales by Country
10.1.1 Latin America Intravenous Immunoglobulin (IVIg) Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.1.2 Latin America Intravenous Immunoglobulin (IVIg) Sales by Country (2019-2024)
10.1.3 Latin America Intravenous Immunoglobulin (IVIg) Sales Forecast by Country (2025-2030)
10.2 Latin America Intravenous Immunoglobulin (IVIg) Market Size by Country
10.2.1 Latin America Intravenous Immunoglobulin (IVIg) Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2.2 Latin America Intravenous Immunoglobulin (IVIg) Market Size by Country (2019-2024)
10.2.3 Latin America Intravenous Immunoglobulin (IVIg) Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST AND AFRICA BY COUNTRY
11.1 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Country
11.1.1 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.1.2 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Country (2019-2024)
11.1.3 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales Forecast by Country (2025-2030)
11.2 Middle East and Africa Intravenous Immunoglobulin (IVIg) Market Size by Country
11.2.1 Middle East and Africa Intravenous Immunoglobulin (IVIg) Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2.2 Middle East and Africa Intravenous Immunoglobulin (IVIg) Market Size by Country (2019-2024)
11.2.3 Middle East and Africa Intravenous Immunoglobulin (IVIg) Market Size Forecast by Country (2025-2030)
12 VALUE CHAIN AND SALES CHANNELS ANALYSIS
12.1 Intravenous Immunoglobulin (IVIg) Value Chain Analysis
12.1.1 Intravenous Immunoglobulin (IVIg) Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Intravenous Immunoglobulin (IVIg) Production Mode & Process
12.2 Intravenous Immunoglobulin (IVIg) Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Intravenous Immunoglobulin (IVIg) Distributors
12.2.3 Intravenous Immunoglobulin (IVIg) Customers
13 CONCLUDING INSIGHTS
14 APPENDIX
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Intravenous Immunoglobulin (IVIg) Market Size Estimates and Forecasts (2019-2030)
1.2.2 Global Intravenous Immunoglobulin (IVIg) Sales Estimates and Forecasts (2019-2030)
1.3 Intravenous Immunoglobulin (IVIg) Market by Type
1.3.1 IVIg Liquid
1.3.2 IVIg Powder
1.4 Global Intravenous Immunoglobulin (IVIg) Market Size by Type
1.4.1 Global Intravenous Immunoglobulin (IVIg) Market Size Overview by Type (2019-2030)
1.4.2 Global Intravenous Immunoglobulin (IVIg) Historic Market Size Review by Type (2019-2024)
1.4.3 Global Intravenous Immunoglobulin (IVIg) Forecasted Market Size by Type (2025-2030)
1.5 Key Regions Market Size by Type
1.5.1 North America Intravenous Immunoglobulin (IVIg) Sales Breakdown by Type (2019-2024)
1.5.2 Europe Intravenous Immunoglobulin (IVIg) Sales Breakdown by Type (2019-2024)
1.5.3 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales Breakdown by Type (2019-2024)
1.5.4 Latin America Intravenous Immunoglobulin (IVIg) Sales Breakdown by Type (2019-2024)
1.5.5 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales Breakdown by Type (2019-2024)
2 GLOBAL MARKET DYNAMICS
2.1 Intravenous Immunoglobulin (IVIg) Industry Trends
2.2 Intravenous Immunoglobulin (IVIg) Industry Drivers
2.3 Intravenous Immunoglobulin (IVIg) Industry Opportunities and Challenges
2.4 Intravenous Immunoglobulin (IVIg) Industry Restraints
3 MARKET COMPETITIVE LANDSCAPE BY COMPANY
3.1 Global Top Players by Intravenous Immunoglobulin (IVIg) Revenue (2019-2024)
3.2 Global Top Players by Intravenous Immunoglobulin (IVIg) Sales (2019-2024)
3.3 Global Top Players by Intravenous Immunoglobulin (IVIg) Price (2019-2024)
3.4 Global Intravenous Immunoglobulin (IVIg) Industry Company Ranking, 2022 VS 2023 VS 2024
3.5 Global Intravenous Immunoglobulin (IVIg) Key Company Manufacturing Sites & Headquarters
3.6 Global Intravenous Immunoglobulin (IVIg) Company, Product Type & Application
3.7 Global Intravenous Immunoglobulin (IVIg) Company Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Intravenous Immunoglobulin (IVIg) Market CR5 and HHI
3.8.2 Global Top 5 and 10 Intravenous Immunoglobulin (IVIg) Players Market Share by Revenue in 2023
3.8.3 2023 Intravenous Immunoglobulin (IVIg) Tier 1, Tier 2, and Tier
4 INTRAVENOUS IMMUNOGLOBULIN (IVIG) REGIONAL STATUS AND OUTLOOK
4.1 Global Intravenous Immunoglobulin (IVIg) Market Size and CAGR by Region: 2019 VS 2023 VS 2030
4.2 Global Intravenous Immunoglobulin (IVIg) Historic Market Size by Region
4.2.1 Global Intravenous Immunoglobulin (IVIg) Sales in Volume by Region (2019-2024)
4.2.2 Global Intravenous Immunoglobulin (IVIg) Sales in Value by Region (2019-2024)
4.2.3 Global Intravenous Immunoglobulin (IVIg) Sales (Volume & Value), Price and Gross Margin (2019-2024)
4.3 Global Intravenous Immunoglobulin (IVIg) Forecasted Market Size by Region
4.3.1 Global Intravenous Immunoglobulin (IVIg) Sales in Volume by Region (2025-2030)
4.3.2 Global Intravenous Immunoglobulin (IVIg) Sales in Value by Region (2025-2030)
4.3.3 Global Intravenous Immunoglobulin (IVIg) Sales (Volume & Value), Price and Gross Margin (2025-2030)
5 INTRAVENOUS IMMUNOGLOBULIN (IVIG) BY APPLICATION
5.1 Intravenous Immunoglobulin (IVIg) Market by Application
5.1.1 Immunodeficiency
5.1.2 Autoimmune Disease
5.1.3 Acute Infection
5.2 Global Intravenous Immunoglobulin (IVIg) Market Size by Application
5.2.1 Global Intravenous Immunoglobulin (IVIg) Market Size Overview by Application (2019-2030)
5.2.2 Global Intravenous Immunoglobulin (IVIg) Historic Market Size Review by Application (2019-2024)
5.2.3 Global Intravenous Immunoglobulin (IVIg) Forecasted Market Size by Application (2025-2030)
5.3 Key Regions Market Size by Application
5.3.1 North America Intravenous Immunoglobulin (IVIg) Sales Breakdown by Application (2019-2024)
5.3.2 Europe Intravenous Immunoglobulin (IVIg) Sales Breakdown by Application (2019-2024)
5.3.3 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales Breakdown by Application (2019-2024)
5.3.4 Latin America Intravenous Immunoglobulin (IVIg) Sales Breakdown by Application (2019-2024)
5.3.5 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales Breakdown by Application (2019-2024)
6 COMPANY PROFILES
6.1 Baxter
6.1.1 Baxter Comapny Information
6.1.2 Baxter Business Overview
6.1.3 Baxter Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Baxter Intravenous Immunoglobulin (IVIg) Product Portfolio
6.1.5 Baxter Recent Developments
6.2 Grifols
6.2.1 Grifols Comapny Information
6.2.2 Grifols Business Overview
6.2.3 Grifols Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Grifols Intravenous Immunoglobulin (IVIg) Product Portfolio
6.2.5 Grifols Recent Developments
6.3 CSL
6.3.1 CSL Comapny Information
6.3.2 CSL Business Overview
6.3.3 CSL Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 CSL Intravenous Immunoglobulin (IVIg) Product Portfolio
6.3.5 CSL Recent Developments
6.4 Octapharma
6.4.1 Octapharma Comapny Information
6.4.2 Octapharma Business Overview
6.4.3 Octapharma Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Octapharma Intravenous Immunoglobulin (IVIg) Product Portfolio
6.4.5 Octapharma Recent Developments
6.5 Biotest
6.5.1 Biotest Comapny Information
6.5.2 Biotest Business Overview
6.5.3 Biotest Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Biotest Intravenous Immunoglobulin (IVIg) Product Portfolio
6.5.5 Biotest Recent Developments
6.6 Kedrion
6.6.1 Kedrion Comapny Information
6.6.2 Kedrion Business Overview
6.6.3 Kedrion Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Kedrion Intravenous Immunoglobulin (IVIg) Product Portfolio
6.6.5 Kedrion Recent Developments
6.7 Hualan Bio
6.7.1 Hualan Bio Comapny Information
6.7.2 Hualan Bio Business Overview
6.7.3 Hualan Bio Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Hualan Bio Intravenous Immunoglobulin (IVIg) Product Portfolio
6.7.5 Hualan Bio Recent Developments
6.8 CNBG
6.8.1 CNBG Comapny Information
6.8.2 CNBG Business Overview
6.8.3 CNBG Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
6.8.4 CNBG Intravenous Immunoglobulin (IVIg) Product Portfolio
6.8.5 CNBG Recent Developments
6.9 Shanghai RAAS
6.9.1 Shanghai RAAS Comapny Information
6.9.2 Shanghai RAAS Business Overview
6.9.3 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Product Portfolio
6.9.5 Shanghai RAAS Recent Developments
6.10 CBPO
6.10.1 CBPO Comapny Information
6.10.2 CBPO Business Overview
6.10.3 CBPO Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
6.10.4 CBPO Intravenous Immunoglobulin (IVIg) Product Portfolio
6.10.5 CBPO Recent Developments
6.11 LFB Group
6.11.1 LFB Group Comapny Information
6.11.2 LFB Group Business Overview
6.11.3 LFB Group Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
6.11.4 LFB Group Intravenous Immunoglobulin (IVIg) Product Portfolio
6.11.5 LFB Group Recent Developments
6.12 BPL
6.12.1 BPL Comapny Information
6.12.2 BPL Business Overview
6.12.3 BPL Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
6.12.4 BPL Intravenous Immunoglobulin (IVIg) Product Portfolio
6.12.5 BPL Recent Developments
6.13 Sichuan Yuanda Shuyang
6.13.1 Sichuan Yuanda Shuyang Comapny Information
6.13.2 Sichuan Yuanda Shuyang Business Overview
6.13.3 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Product Portfolio
6.13.5 Sichuan Yuanda Shuyang Recent Developments
7 NORTH AMERICA BY COUNTRY
7.1 North America Intravenous Immunoglobulin (IVIg) Sales by Country
7.1.1 North America Intravenous Immunoglobulin (IVIg) Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.1.2 North America Intravenous Immunoglobulin (IVIg) Sales by Country (2019-2024)
7.1.3 North America Intravenous Immunoglobulin (IVIg) Sales Forecast by Country (2025-2030)
7.2 North America Intravenous Immunoglobulin (IVIg) Market Size by Country
7.2.1 North America Intravenous Immunoglobulin (IVIg) Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2.2 North America Intravenous Immunoglobulin (IVIg) Market Size by Country (2019-2024)
7.2.3 North America Intravenous Immunoglobulin (IVIg) Market Size Forecast by Country (2025-2030)
8 EUROPE BY COUNTRY
8.1 Europe Intravenous Immunoglobulin (IVIg) Sales by Country
8.1.1 Europe Intravenous Immunoglobulin (IVIg) Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.1.2 Europe Intravenous Immunoglobulin (IVIg) Sales by Country (2019-2024)
8.1.3 Europe Intravenous Immunoglobulin (IVIg) Sales Forecast by Country (2025-2030)
8.2 Europe Intravenous Immunoglobulin (IVIg) Market Size by Country
8.2.1 Europe Intravenous Immunoglobulin (IVIg) Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2.2 Europe Intravenous Immunoglobulin (IVIg) Market Size by Country (2019-2024)
8.2.3 Europe Intravenous Immunoglobulin (IVIg) Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC BY COUNTRY
9.1 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales by Country
9.1.1 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.1.2 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales by Country (2019-2024)
9.1.3 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales Forecast by Country (2025-2030)
9.2 Asia-Pacific Intravenous Immunoglobulin (IVIg) Market Size by Country
9.2.1 Asia-Pacific Intravenous Immunoglobulin (IVIg) Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2.2 Asia-Pacific Intravenous Immunoglobulin (IVIg) Market Size by Country (2019-2024)
9.2.3 Asia-Pacific Intravenous Immunoglobulin (IVIg) Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA BY COUNTRY
10.1 Latin America Intravenous Immunoglobulin (IVIg) Sales by Country
10.1.1 Latin America Intravenous Immunoglobulin (IVIg) Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.1.2 Latin America Intravenous Immunoglobulin (IVIg) Sales by Country (2019-2024)
10.1.3 Latin America Intravenous Immunoglobulin (IVIg) Sales Forecast by Country (2025-2030)
10.2 Latin America Intravenous Immunoglobulin (IVIg) Market Size by Country
10.2.1 Latin America Intravenous Immunoglobulin (IVIg) Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2.2 Latin America Intravenous Immunoglobulin (IVIg) Market Size by Country (2019-2024)
10.2.3 Latin America Intravenous Immunoglobulin (IVIg) Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST AND AFRICA BY COUNTRY
11.1 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Country
11.1.1 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.1.2 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Country (2019-2024)
11.1.3 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales Forecast by Country (2025-2030)
11.2 Middle East and Africa Intravenous Immunoglobulin (IVIg) Market Size by Country
11.2.1 Middle East and Africa Intravenous Immunoglobulin (IVIg) Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2.2 Middle East and Africa Intravenous Immunoglobulin (IVIg) Market Size by Country (2019-2024)
11.2.3 Middle East and Africa Intravenous Immunoglobulin (IVIg) Market Size Forecast by Country (2025-2030)
12 VALUE CHAIN AND SALES CHANNELS ANALYSIS
12.1 Intravenous Immunoglobulin (IVIg) Value Chain Analysis
12.1.1 Intravenous Immunoglobulin (IVIg) Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Intravenous Immunoglobulin (IVIg) Production Mode & Process
12.2 Intravenous Immunoglobulin (IVIg) Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Intravenous Immunoglobulin (IVIg) Distributors
12.2.3 Intravenous Immunoglobulin (IVIg) Customers
13 CONCLUDING INSIGHTS
14 APPENDIX
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
